The world's need for radiopharmaceuticals is growing steadily. The key to growth and greater utilization of molecular imaging is the development of new and more specific biomarkers. At PETNET Solutions, we consider this to be the next step in expanding molecular diagnostics from research to patient care.

That's why PETNET Solutions is collaborating with some of the world's leading research organizations to develop specific molecular biomarkers that will allow physicians to transition from treating the illness to treating the individual. We are about to enter an era of extraordinary change where these new biomarkers will expand the boundaries of molecular imaging and lead us to the promise of personalized medicine. Now that is progress.